Cigna Plans to Limit Out-Of-Pocket Drug Costs for US Patients
Cigna Group plans to limit patients’ out-of-pocket expenses for medications as the insurer faces pressure from Washington ...
The University of Chicago Chronicle7h
Collaboration to provide up to $130 million to fuel drug discovery, development at UChicago
Launch of Hyde Park Discovery between UChicago, Deerfield Management to accelerate research into life-saving treatments ...
AN2 Therapeutics' SWOT analysis: stock pivot after epetraborole setback
AN2 Therapeutics , Inc. (NASDAQ:ANTX), currently trading at $1.23 and showing a significant 93.54% decline over the past year ...
manilatimes22h
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides a Corporate Update
Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and ...